EU AI Act Legal Deep-Dive Part 2: Balancing Medtech Innovation With Safety
Cooley lawyers Elizabeth Anne Wright, Edward Turtle, Patrick Van Eecke and Daniel Millard were quoted in part two of Medtech Insight’s two-part series on the European Commission’s proposed AI Act, forecasting the impact the act might have on conformity assessments and patient access to innovative healthcare products and highlighting areas for improvement in the draft text, as well as analyzing how the European Union approach to regulating artificial intelligence differs from that of the UK.
This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.